Joseph Y. Chang - 01 Mar 2023 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
Chief Scientific Officer
Signature
/s/ Gregory Belliston as Attorney-in-Fact for Joseph Y. Chang
Issuer symbol
NUS
Transactions as of
01 Mar 2023
Net transactions value
-$929,730
Form type
4
Filing time
03 Mar 2023, 17:32:02 UTC
Previous filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUS Class A Common Stock Options Exercise $2,097,696 +68,485 +323% $30.63 89,719 01 Mar 2023 Direct
transaction NUS Class A Common Stock Sale $2,769,533 -68,485 -76% $40.44 21,234 01 Mar 2023 Direct F1
transaction NUS Class A Common Stock Options Exercise $18,378 +600 +2.8% $30.63 21,834 02 Mar 2023 Direct
transaction NUS Class A Common Stock Options Exercise $742,980 +24,400 +112% $30.45 46,234 02 Mar 2023 Direct
transaction NUS Class A Common Stock Sale $1,019,250 -25,000 -54% $40.77 21,234 02 Mar 2023 Direct F2
holding NUS Class A Common Stock 78,068 01 Mar 2023 Held in irrevocable family trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -42,485 -100% $0.000000* 0 01 Mar 2023 Class A Common Stock 42,485 $30.63 Direct F4
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -26,000 -98% $0.000000 600 01 Mar 2023 Class A Common Stock 26,000 $30.63 Direct F4
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -600 -100% $0.000000* 0 02 Mar 2023 Class A Common Stock 600 $30.63 Direct F4
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -24,400 -29% $0.000000 59,410 02 Mar 2023 Class A Common Stock 24,400 $30.45 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3 This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4 Currently exercisable in full.